1. Germline variation in inflammation-related pathways and risk of Barrett's oesophagus and oesophageal adenocarcinoma. Issue 10 (2nd August 2016) Authors: Buas, Matthew F; He, Qianchuan; Johnson, Lisa G; Onstad, Lynn; Levine, David M; Thrift, Aaron P; Gharahkhani, Puya; Palles, Claire; Lagergren, Jesper; Fitzgerald, Rebecca C; Ye, Weimin; Caldas, Carlos; Bird, Nigel C; Shaheen, Nicholas J; Bernstein, Leslie; Gammon, Marilie D; Wu, Anna H; Hardie, L... Journal: Gut Issue: Volume 66:Issue 10(2017) Page Start: 1739 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Germline variation in the insulin-like growth factor pathway and risk of Barrett's esophagus and esophageal adenocarcinoma. (10th December 2020) Authors: Dighe, Shruti G; Chen, Jianhong; Yan, Li; He, Qianchuan; Gharahkhani, Puya; Onstad, Lynn; Levine, David M; Palles, Claire; Ye, Weimin; Gammon, Marilie D; Iyer, Prasad G; Anderson, Lesley A; Liu, Geoffrey; Wu, Anna H; Dai, James Y; Chow, Wong-Ho; Risch, Harvey A; Lagergren, Jesper; Shaheen, Nichol... Journal: Carcinogenesis Issue: Volume 42:Number 3(2021) Page Start: 369 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Neutralising antibody potency against SARS-CoV-2 wild-type and omicron BA.1 and BA.4/5 variants in patients with inflammatory bowel disease treated with infliximab and vedolizumab after three doses of COVID-19 vaccine (CLARITY IBD): an analysis of a prospective multicentre cohort study. (February 2023) Authors: Liu, Zhigang; Le, Kaixing; Zhou, Xin; Alexander, James L; Lin, Simeng; Bewshea, Claire; Chanchlani, Neil; Nice, Rachel; McDonald, Timothy J; Lamb, Christopher A; Sebastian, Shaji; Kok, Klaartje; Lees, Charlie W; Hart, Ailsa L; Pollok, Richard C; Boyton, Rosemary J; Altmann, Daniel M; Pollock, Kat... Journal: Lancet gastroenterology and hepatology Issue: Volume 8:Number 2(2023) Page Start: 145 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗